MedTrace Logo

Sequential Endoscopic Lung Volume Reduction

NCT00613860 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2022-09-02

No results posted yet for this study

Summary

Patients with heterogenous emphysema benefits from endoscopic lung volume reduction. Until now the technique is limited to one lobe. In case of collateral ventilation patients show no improvement. Between upper and middle lobe exists the highest collateral flow. The trial examine the hypothesis, that sequential ELVR help especially those patients, which have no benefit after lobar exclusion.

Conditions

Interventions

DEVICE

Zephyr endobronchial valve

Endobronchial valve system to redirect the airflow within the bronchial system

Sponsors & Collaborators

  • Humboldt-Universität zu Berlin

    collaborator OTHER

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Felix JF Herth, MD, PhD · Thoraxklinik University of Heidelberg

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-12-31
Completion
2012-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00613860 on ClinicalTrials.gov